Vancomycin Powder for Concentrate for Solution for Infusion - small particles of fibre material and glass in individual vials
(ITH Pharma Ltd) Remaining stocks should be quarantined and returned to original supplier for credit - class 2 action within 48 hours. (EL (14)A/06)
12 June 2014
Class 2 medicines recall
Action within 48 hours
Hospital ward, pharmacy, clinic and wholesale level
MDR 16-06/14
Product details
Actavis Group PTC ehf
Vancomycin Powder for Concentrate for Solution for Infusion 500mg - PL 30306/0444
Vancomycin Powder for Concentrate for Solution for Infusion 1000mg - PL 30306/0445
Alert details
Product | Batch number | Expiry date | First distributed | |||
---|---|---|---|---|---|---|
Vancomycin Powder for Infusion 500mg | 5001039 | Mar-2015 | 26-Jun-2013 | |||
5001066 | Apr-2015 | 15-Jul-2013 | ||||
5001177 | Jul-2015 | 13-Sep-2013 | ||||
5001231 | Aug-2015 | 16-Dec-2013 | ||||
5000830 | Oct-2014 | 14-Feb-2013 | ||||
Vancomycin Powder for Concentrate for Solution for Infusion 1000mg | 5001102 | May-2015 | 18-Sep-2013 | |||
5001128 | Jun-2015 | 27-Dec-2013 | ||||
5001034 | Mar-2015 | 17-Oct-2013 | ||||
5001190 | Jul-2015 | 27-May-2014 |
Actavis is recalling all remaining stock of the above batches to hospital ward, pharmacy, clinic and wholesale level. This is due to the potential for small particles of fibre material and glass to be present in individual vials, identified by Actavis’ third party manufacturer.
Remaining stocks of the affected batches should be quarantined and returned to the original supplier for credit. For enquiries relating to stock returns please contact Actavis Customer Services on 0800 373 573.
For medical information enquiries please contact Actavis Medical Information Department on 01271 385 257.
Recipients of this drug alert should bring it to the attention of relevant contacts by copy of this letter.